Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

NatureCellLtd

Market Cap: ₩1.3t

Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.

ScinoPharm Taiwan

Market Cap: NT$14.9b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.

Prescient Therapeutics

Market Cap: AU$43.6m

A clinical stage oncology company, develops drugs for the treatment of various cancers in Australia.

JW Pharmaceutical

Market Cap: ₩487.2b

Manufactures and sells medicines and medical supplies in Japan and internationally.

Merck KGaA

Market Cap: €46.2b

Operates as a science and technology company in Germany.

Elicera Therapeutics

Market Cap: SEK 233.0m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Karolinska Development

Market Cap: SEK 242.8m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

2invest

Market Cap: €74.4m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.

Dextech Medical

Market Cap: SEK 132.2m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

Cheilbio

Market Cap: ₩56.2b

Cheilbio Co., Ltd. produces and sells veterinary products for pig, cattle, chicken, aqua, and other animals in South Korea.

S.C. Sintofarm

Market Cap: RON 16.6m

Develops pharmaceutical products in Romania.

SLS BIO

Market Cap: ₩26.9b

Develops diagnostic technologies in South Korea.

Pharmesis International

Market Cap: S$14.4m

An investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China.

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س10.6b

Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.

IBN SINA Pharmaceutical Industry

Market Cap: ৳9.8b

Produces and sells pharmaceutical drugs in Bangladesh and internationally.

InflaRx

Market Cap: US$92.1m

A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.

Psyence Biomedical

Market Cap: US$1.9m

Engages in the development of botanical psilocybin-based psychedelic medicines.

Reflect Scientific

Market Cap: US$4.5m

Through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide.

Larimar Therapeutics

Market Cap: US$436.5m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Bonesupport Holding

Market Cap: SEK 18.9b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Elite Pharmaceuticals

Market Cap: US$681.6m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Spermosens

Market Cap: SEK 24.1m

Provides diagnostic health care products and services in Sweden.

Apogee Therapeutics

Market Cap: US$2.3b

A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications.

Eledon Pharmaceuticals

Market Cap: US$144.9m

Operates as a clinical stage biotechnology company.

Stoke Therapeutics

Market Cap: US$1.3b

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

CytoMed Therapeutics

Market Cap: US$23.4m

A pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore.

Incyte

Market Cap: US$16.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Sunshine Biopharma

Market Cap: US$7.1m

Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.

Terns Pharmaceuticals

Market Cap: US$688.7m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Tiziana Life Sciences

Market Cap: US$219.6m

A biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States.

BIOTON

Market Cap: zł390.7m

A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.

Cidara Therapeutics

Market Cap: US$2.2b

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Respiratorius

Market Cap: €19.4m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

Cabaletta Bio

Market Cap: US$225.9m

A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.

Fulcrum Therapeutics

Market Cap: US$446.3m

A clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.

Opus Genetics

Market Cap: US$103.4m

A clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs).